🇺🇸 FDA
Patent

US 11154573

Methods of generating T-cells from stem cells and immunotherapeutic methods using the T-cells

granted A61KA61K40/11A61K40/31

Quick answer

US patent 11154573 (Methods of generating T-cells from stem cells and immunotherapeutic methods using the T-cells) held by The Regents of the University of California expires Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
34
CPC classes
A61K, A61K40/11, A61K40/31, A61K40/32, A61K40/42